Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07048106

Progression Assessment of PXE-associated Alterations

This monocentric clinical observational study at the University Eye Hospital Bonn investigates the natural history and structural consequences of a diseased Bruch's membrane (BrM) in Pseudoxanthoma elasticum (PXE). The study includes four main objectives:

1. Direct Bruch's Membrane Alterations: Longitudinal analysis of BrM reflectivity using high-resolution OCT to assess correlations with disease progression 2. Choriocapillaris Flow Deficits: Evaluation of choriocapillaris (CC) perfusion in relation to BrM calcification, aiming to clarify whether CC deficits precede or result from BrM changes 3. Retinal Atrophy Progression: Monitoring the development and expansion of retinal atrophic areas over two years, including correlations with specific features like reticular pseudodrusen and hyperreflective spots 4. Genotype-Phenotype Correlation: Analysis of different ABCC6 gene mutations to identify correlations with imaging features and disease severity, potentially guiding future personalized therapeutic strategies

The study will recruit 100 PXE patients and 100 controls, with data collection over 10 years. It involves non-invasive imaging and blood sampling. No direct benefit is expected for participants, but the findings may inform future clinical trials and improve patient counseling.

Recruiting

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for PXE cohort:

  • PXE based on the criteria of Plomp et al.
  • Clear ocular media
  • Ability to perform the tasks of the study protocol (i.e., holding the head still for image aquisition)

Exclusion criteria

  • Any confounding ocular disease not associated with PXE
  • Systemic diseases hindering the study examinations

Treatment and study plan

Primary outcomes

  1. Eccentricity of 'Peau d'orange' over 2 years

    Time frame: 2 years

    'Peau d'orange' will be measured in en-face imaging [mm2]

Secondary outcomes

  1. Bruch's Membrane changes on High-Resolution Optical coherence tomography (OCT)

    Time frame: 2 years

    Bruch's membrane will be qualitatively graded on High resolution OCT (integrity, breaks, ...)

  2. Choriocapillaris flow voids on Optical Coherence Tomography Angiography (OCT-A)

    Time frame: 2 years

    Choriocapillaris degeneration will be evaluated on OCT-Angiography, i.e. percent (%) of flow voids, progression over 2 years

  3. Angioid Streak Length on Fundus Photography and Infrared Reflectance Imaging

    Time frame: 2 years

    Angioid Streaks will be measured manually with the unit [mm]

Study contacts

Contact information is provided by the study sponsor or research team.

Kristina Pfau, MD, FEBO

CONTACT

[email protected]

+49 (0)228-287 15505

Sponsors and collaborators

Lead sponsor

University Hospital, Bonn

Other

Registry information

Official study title

Natural History and Structural Consequences of a Diseased Bruch's Membrane in Pseudoxanthoma Elasticum (PXE)

Acronym: PAPA

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Jul 2, 2025
Registry last updated
Jul 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.